Los Angeles Capital Management LLC Ovid Therapeutics Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.3 - $4.49 $14,850 - $20,205	-4,500 Reduced 13.69%	28,360 $111,000
Q1 2021 May 05, 2021	SELL	$2.42 - $4.47 $100,454 - $185,549	-41,510 Reduced 55.82%	32,860 $132,000
Q4 2020 Feb 04, 2021	BUY	$2.28 - $6.84 $7,227 - $21,682	3,170 Added 4.45%	74,370 $172,000
Q3 2020 Nov 02, 2020	SELL	$5.39 - $8.24 $48,402 - $73,995	-8,980 Reduced 11.2%	71,200 $409,000
Q2 2020 Aug 05, 2020	BUY	$2.67 - $7.91 $214,080 - $634,223	80,180 New	80,180 $590,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.